These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

118 related articles for article (PubMed ID: 31013002)

  • 1. Production of Brucella lumazine Synthase Recombinant Protein to Design a Subunit Vaccine against Undulant Fever.
    Akbari R; Sekhavati MH; Bahrami A; Majidzadeh Heravi R; Yousefi S
    Arch Razi Inst; 2019 Mar; 74(1):1-6. PubMed ID: 31013002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of immune responses induced by polymeric OMP25-BLS Brucella antigen.
    Yousefi S; Abbassi-Daloii T; Sekhavati MH; Tahmoorespur M
    Microb Pathog; 2018 Feb; 115():50-56. PubMed ID: 29253594
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A recombinant subunit vaccine based on the insertion of 27 amino acids from Omp31 to the N-terminus of BLS induced a similar degree of protection against B. ovis than Rev.1 vaccination.
    Cassataro J; Pasquevich KA; Estein SM; Laplagne DA; Velikovsky CA; de la Barrera S; Bowden R; Fossati CA; Giambartolomei GH; Goldbaum FA
    Vaccine; 2007 May; 25(22):4437-46. PubMed ID: 17442465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunoproteomic analysis of Brucella melitensis and identification of a new immunogenic candidate protein for the development of brucellosis subunit vaccine.
    Yang Y; Wang L; Yin J; Wang X; Cheng S; Lang X; Wang X; Qu H; Sun C; Wang J; Zhang R
    Mol Immunol; 2011 Oct; 49(1-2):175-84. PubMed ID: 21943783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy evaluation of live Escherichia coli expression Brucella P39 protein combined with CpG oligodeoxynucleotides vaccine against Brucella melitensis 16M, in BALB/c mice.
    Al-Mariri A; Mahmoud NH; Hammoud R
    Biologicals; 2012 Mar; 40(2):140-5. PubMed ID: 22296786
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Design and Production of a Novel Recombinant Chimeric IL2-Omp31 Antigen against Brucella Infection.
    Naghavi M; Sekhavati MH; Tahmoorespur M; Nassiri MR
    Arch Razi Inst; 2018 Sep; 73(3):199-206. PubMed ID: 30280839
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunization of mice with a novel recombinant molecular chaperon confers protection against Brucella melitensis infection.
    Ghasemi A; Jeddi-Tehrani M; Mautner J; Salari MH; Zarnani AH
    Vaccine; 2014 Nov; 32(49):6659-66. PubMed ID: 25240754
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cloning, expression and molecular analysis of Iranian
    Yousefi S; Tahmoorespur M; Sekhavati MH
    Res Pharm Sci; 2016 Oct; 11(5):412-418. PubMed ID: 27920824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunization of mice with recombinant S-adenosyl-L-homocysteine hydrolase protein confers protection against Brucella melitensis infection.
    Yang Y; Yin J; Guo D; Lang X; Wang X
    FEMS Immunol Med Microbiol; 2011 Mar; 61(2):159-67. PubMed ID: 21166726
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Brucella lumazine synthase elicits a mixed Th1-Th2 immune response and reduces infection in mice challenged with Brucella abortus 544 independently of the adjuvant formulation used.
    Velikovsky CA; Goldbaum FA; Cassataro J; Estein S; Bowden RA; Bruno L; Fossati CA; Giambartolomei GH
    Infect Immun; 2003 Oct; 71(10):5750-5. PubMed ID: 14500496
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Identification of a new immunogenic candidate conferring protection against Brucella melitensis infection in mice.
    Ghasemi A; Zarnani AH; Ghoodjani A; Rezania S; Salari MH; Jeddi-Tehrani M
    Mol Immunol; 2014 Nov; 62(1):142-9. PubMed ID: 24995396
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The Brucella melitensis M5-90ΔmanB live vaccine candidate is safer than M5-90 and confers protection against wild-type challenge in BALB/c mice.
    Zhang J; Yin S; Yi D; Zhang H; Li Z; Guo F; Chen C; Fang W; Wang J
    Microb Pathog; 2017 Nov; 112():148-155. PubMed ID: 28916316
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Evaluation of the immunogenicity and the protective efficacy in mice of a DNA vaccine encoding SP41 from Brucella melitensis.
    Al-Mariri A; Abbady AQ
    J Infect Dev Ctries; 2013 Apr; 7(4):329-37. PubMed ID: 23592643
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody response to Brucella melitensis outer membrane antigens in naturally infected and Rev1 vaccinated sheep.
    Zygmunt MS; Debbarh HS; Cloeckaert A; Dubray G
    Vet Microbiol; 1994 Mar; 39(1-2):33-46. PubMed ID: 8203126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. In vivo immunogenicity assessment and vaccine efficacy evaluation of a chimeric tandem repeat of epitopic region of OMP31 antigen fused to interleukin 2 (IL-2) against Brucella melitensis in BALB/c mice.
    Nazifi N; Tahmoorespur M; Sekhavati MH; Haghparast A; Behroozikhah AM
    BMC Vet Res; 2019 Nov; 15(1):402. PubMed ID: 31703683
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protection of mice from Brucella infection by immunization with attenuated Salmonella enterica serovar typhimurium expressing A L7/L12 and BLS fusion antigen of Brucella.
    Zhao Z; Li M; Luo D; Xing L; Wu S; Duan Y; Yang P; Wang X
    Vaccine; 2009 Aug; 27(38):5214-9. PubMed ID: 19596411
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Epitope mapping of the Brucella melitensis BP26 immunogenic protein: usefulness for diagnosis of sheep brucellosis.
    Seco-Mediavilla P; Verger JM; Grayon M; Cloeckaert A; Marín CM; Zygmunt MS; Fernández-Lago L; Vizcaíno N
    Clin Diagn Lab Immunol; 2003 Jul; 10(4):647-51. PubMed ID: 12853399
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification of potential antigens from non-classically secreted proteins and designing novel multitope peptide vaccine candidate against Brucella melitensis through reverse vaccinology and immunoinformatics approach.
    Vishnu US; Sankarasubramanian J; Gunasekaran P; Rajendhran J
    Infect Genet Evol; 2017 Nov; 55():151-158. PubMed ID: 28919551
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Protection of BALB/c mice against homologous and heterologous species of Brucella by rough strain vaccines derived from Brucella melitensis and Brucella suis biovar 4.
    Winter AJ; Schurig GG; Boyle SM; Sriranganathan N; Bevins JS; Enright FM; Elzer PH; Kopec JD
    Am J Vet Res; 1996 May; 57(5):677-83. PubMed ID: 8723881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Enhanced efficacy of recombinant Brucella abortus RB51 vaccines against B. melitensis infection in mice.
    Vemulapalli R; Contreras A; Sanakkayala N; Sriranganathan N; Boyle SM; Schurig GG
    Vet Microbiol; 2004 Sep; 102(3-4):237-45. PubMed ID: 15327798
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.